all report title image
  • Published On : May 2023
  • Code : CMI5709
  • Industry : Pharmaceutical
  • Pages : 155
  • Formats :

The global poultry antibiotic market size was valued at US$ 3.45 billion in 2022. The market is expected to experience a moderate growth rate in the coming years, with a projected CAGR of 5.8% from 2022 to 2030. This would result in an estimated market size of US$ 5.41 billion by the end of 2030.

The growth of the market is expected to be driven by factors such as the increasing demand for poultry products, the prevalence of various poultry diseases, and the rise in animal health concerns. However, the market is also facing challenges due to the negative impact of antibiotics on human health, which has led to strict regulations and the adoption of alternative strategies such as vaccination and probiotics. Overall, the poultry antibiotic market is expected to continue growing, albeit at a slower rate, in the coming years.

Poultry Antibiotic Market Regional Insights

North America held the largest share of the global poultry antibiotic market in 2022, accounting for over 34% of the total market. The region is expected to continue dominating the market during the forecast period due to the high demand for poultry products, the prevalence of various poultry diseases, and the presence of major market players.

Europe held the second-largest share of the market in 2022, with a significant contribution from countries like France, Germany, and the United Kingdom. However, the region is expected to witness slower growth during the forecast period due to the increasing focus on antibiotic-free poultry production and stricter regulations on antibiotic use in animal feed.

The Asia-Pacific region is expected to witness significant growth during the forecast period, driven by factors such as increasing population, changing food preferences, and rising demand for high-quality protein sources. China and India are expected to be the major contributors to the growth of the poultry antibiotic market in the region.

Poultry Antibiotic Market Drivers:

  1. Increasing demand for poultry products: The global population is increasing, and so is the demand for protein sources, including poultry products. This has led to a rise in poultry production, which in turn has increased the demand for antibiotics to prevent and treat poultry diseases.
  2. Prevalence of various poultry diseases: Poultry diseases such as avian influenza, Newcastle disease, and coccidiosis are common and can have a significant impact on poultry production. Antibiotics are often used to prevent and treat these diseases, driving demand for antibiotics in the poultry industry.
  3. Rise in animal health concerns: Consumers are increasingly concerned about the health and welfare of animals, including those in the poultry industry. This has led to a greater focus on disease prevention and treatment, which in turn has increased demand for antibiotics.
  4. Technological advancements in the poultry industry: Advances in technology have led to improved methods of poultry production, including more intensive production methods. These methods can increase the risk of disease transmission and therefore increase the need for antibiotics.

Poultry Antibiotic Market Opportunities:

  1. Development of antibiotic alternatives: Due to concerns about antibiotic resistance and human health, there is a growing need for alternative strategies for disease prevention and treatment in the poultry industry. This presents an opportunity for the development of new and innovative products, such as vaccines and probiotics.
  2. Expansion into emerging markets: As standards of living improve in emerging markets, there is a corresponding increase in demand for animal protein sources, including poultry. This presents an opportunity for companies to expand their presence in these markets and capture a share of the growing demand.
  3. Investment in research and development: Investment in research and development can lead to the development of new and improved antibiotics and other products for disease prevention and treatment in the poultry industry. This can help companies to stay ahead of the competition and meet the changing needs of consumers and regulators.
  4. Adoption of sustainable production practices: Sustainable production practices, such as organic and free-range farming, are becoming increasingly popular among consumers. This presents an opportunity for companies to differentiate themselves by offering antibiotic-free or reduced-antibiotic products.

Poultry Antibiotic Market Trends:

  1. Adoption of antibiotic-free and reduced-antibiotic production: As concerns about antibiotic resistance and human health continue to grow, there is an increasing trend towards antibiotic-free and reduced-antibiotic production in the poultry industry. This is driving demand for alternative disease prevention and treatment strategies.
  2. Focus on animal welfare: Consumers are becoming more concerned about the welfare of animals, including those in the poultry industry. This is leading to a greater focus on disease prevention and treatment, as well as the adoption of more humane production practices.
  3. Shift towards natural and organic products: There is a growing trend towards natural and organic products in the food industry, including the poultry industry. This is driving demand for antibiotic-free and organic poultry products, and presenting opportunities for companies to differentiate themselves in the market.
  4. Increased regulation of antibiotic use: Governments and regulatory bodies around the world are increasingly regulating the use of antibiotics in the poultry industry, in order to combat antibiotic resistance and protect human health. This is leading to the adoption of alternative disease prevention and treatment strategies.
CMI table icon

Poultry Antibiotic Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2022: US$ 3.45 Bn
Historical Data for: 2017 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.8% 2030 Value Projection: US$ 5.41 Bn
Geographies covered:
  • By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Segments covered:
  • By Product Type: Penicillins, Tetracyclines, Macrolides, Fluoroquinolones, Aminoglycosides, Others
  • By Mode of Administration: Oral, Injection, Others
Companies covered:

Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck & Co. Inc., Bayer AG, Ceva Santé Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Huvepharma, Neogen Corporation, Nisseiken Co., Ltd., , Inovio Pharmaceuticals, Inc., Venky's (India) Limited

Growth Drivers:
  • Increasing demand for poultry products
  • Prevalence of various poultry diseases
  • Rise in animal health concerns
  • Technological advancements in the poultry industry
Restraints & Challenges:
  • Concerns about antibiotic resistance
  • Stringent regulations
  • Adoption of alternative disease prevention and treatment strategies

Poultry Antibiotic Market Restraints:

  1. Concerns about antibiotic resistance: The overuse of antibiotics in the poultry industry has led to concerns about antibiotic resistance, which can have serious implications for human health. This has led to increased regulation and a shift towards alternative disease prevention and treatment strategies.
  2. Stringent regulations: Governments and regulatory bodies around the world are increasingly regulating the use of antibiotics in the poultry industry, in order to combat antibiotic resistance and protect human health. This is leading to greater scrutiny and restrictions on the use of antibiotics in animal feed.
  3. Adoption of alternative disease prevention and treatment strategies: The adoption of alternative disease prevention and treatment strategies, such as vaccination and probiotics, is reducing the demand for antibiotics in the poultry industry.

Recent Developments

New product launches

  1. MINTREX® Poultry: In 2020, Novus International launched MINTREX® Poultry, a chelated trace mineral supplement designed to improve gut health and support the immune system in poultry.
  2. Gallipro Tect: In 2019, Phibro Animal Health Corporation launched Gallipro Tect, a vaccine for the prevention of Salmonella infections in poultry.
  3. Biotica800: In 2018, DuPont Animal Nutrition launched Biotica800, a probiotic for use in poultry production that helps improve gut health and support the immune system.

Acquisition and partnerships in Poultry Antibiotic Market

  1. Elanco's acquisition of Bayer Animal Health: In 2020, Elanco completed its acquisition of Bayer Animal Health for $7.6 billion. This acquisition expanded Elanco's portfolio of animal health products, including poultry antibiotics.
  2. Cargill and Delacon partnership: In 2019, Cargill and Delacon announced a strategic partnership to bring phytogenic feed additives to the global poultry industry. This partnership aimed to provide an alternative to antibiotics in poultry production.
  3. Boehringer Ingelheim's acquisition of Merial: In 2017, Boehringer Ingelheim completed its acquisition of Merial, the animal health division of Sanofi, for $13.5 billion. This acquisition expanded Boehringer Ingelheim's portfolio of animal health products, including poultry antibiotics.

Top companies in Poultry Antibiotic Market

  1. Zoetis Inc.
  2. Elanco Animal Health
  3. Boehringer Ingelheim Animal Health
  4. Merck & Co. Inc.
  5. Bayer AG
  6. Ceva Santé Animale
  7. Virbac
  8. Vetoquinol S.A.
  9. Phibro Animal Health Corporation
  10. Huvepharma
  11. Neogen Corporation
  12. Nisseiken Co., Ltd.
  13. Inovio Pharmaceuticals, Inc.
  14. Venky's (India) Limited

Poultry antibiotics are primarily used to treat infectious diseases as well as preventative treatment for birds (chickens, turkeys, geese, and ducks) raised commercially or domestically for meat, eggs, and feathers. Antibiotics help make food safe by keeping chickens healthy and reducing bacteria entering the food supply. Antibiotics in poultry are generally administered to the entire flock and are used for the treatment of disease, disease prevention, and growth promotion.

Market Dynamics:

Increase in population of chickens, rise in consumption of eggs and meat, rise in focus on poultry healthcare, increase in awareness among people, and increase in demand for safe/effective poultry antibiotics are major factors expected to drive growth of the global poultry antibiotic market.

For instance, in February 2023, AgriFutures Australia announced a 5-year research, development, and extension plan for Australia’s AUS$$6.6 billion chicken meat industry.

Moreover, in December 2022, Avec announced the launch of Sustainability Charter which outlines areas where the poultry industry can improve on its environmental sustainability like packaging, animal welfare, and use of antibiotics.

Key features of the study:

  • This report provides in-depth analysis of the global poultry antibiotic market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global poultry antibiotic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Venky's (India) Limited, Inovio Pharmaceuticals, Inc., Nisseiken Co., Ltd., Neogen Corporation, Huvepharma, Vetoquinol S.A., Virbac, Ceva Santé Animale, Bayer AG, Merck & Co. Inc., Elanco Animal Health, Zoetis Inc., Phibro Animal Health Corporation, and Boehringer Ingelheim Animal Health, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global poultry antibiotic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry antibiotic market.

Detailed Segmentation:

  • Global Poultry Antibiotic Market, By Product Type:
    • Penicillins
    • Tetracyclines
    • Macrolides
    • Fluoroquinolones
    • Aminoglycosides
    • Others
  • Global Poultry Antibiotic Market, By Mode of Administration:
    • Oral
    • Injection
    • Others
  • Global Poultry Antibiotic Market, By Geography: 
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Venky's (India) Limited
    • Inovio Pharmaceuticals, Inc.
    • Nisseiken Co., Ltd.
    • Neogen Corporation
    • Huvepharma
    • Vetoquinol S.A.
    • Virbac
    • Ceva Santé Animale
    • Bayer AG
    • Merck & Co. Inc.
    • Elanco Animal Health
    • Zoetis Inc.
    • Phibro Animal Health Corporation
    • Boehringer Ingelheim Animal Health

Frequently Asked Questions

The global poultry antibiotic market size was valued at US$ 3.45 Bn in 2022 and is expected to reach US$ 5.41 Bn by 2030.
Increasing demand for poultry products is expected to drive the market.
The North America region will lead the in market.
The market growing at a CAGR of 5.8% during the forecast period.
Major players operating in the market include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck & Co. Inc., Bayer AG, Ceva Santé Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Huvepharma, Neogen Corporation, Nisseiken Co., Ltd., Inovio Pharmaceuticals, Inc., Venky's (India) Limited

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo